These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 11313868

  • 41. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC.
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [Abstract] [Full Text] [Related]

  • 42. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 43. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
    Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H, Tahara E.
    Cancer Res; 1992 Jan 15; 52(2):295-300. PubMed ID: 1309437
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter.
    Oettgen P, Barcinski M, Boltax J, Stolt P, Akbarali Y, Libermann TA.
    Genomics; 1999 Feb 01; 55(3):358-62. PubMed ID: 10049594
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
    Mi Y, Borger DR, Fernandes PR, Pirisi L, Creek KE.
    Virology; 2000 May 10; 270(2):408-16. PubMed ID: 10793000
    [Abstract] [Full Text] [Related]

  • 53. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor.
    Choi SG, Yi Y, Kim YS, Kato M, Chang J, Chung HW, Hahm KB, Yang HK, Rhee HH, Bang YJ, Kim SJ.
    J Biol Chem; 1998 Jan 02; 273(1):110-7. PubMed ID: 9417054
    [Abstract] [Full Text] [Related]

  • 54. Transforming growth factor-beta receptor expression in human cornea.
    Joyce NC, Zieske JD.
    Invest Ophthalmol Vis Sci; 1997 Sep 02; 38(10):1922-8. PubMed ID: 9331255
    [Abstract] [Full Text] [Related]

  • 55. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B, Jang JS, Park K.
    Int J Oncol; 2000 Sep 02; 17(3):473-8. PubMed ID: 10938386
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
    Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC.
    Oncogene; 1997 Apr 03; 14(13):1617-22. PubMed ID: 9129154
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.